KVUE - Kenvue Inc Qarzning balans kapitallashuviga nisbati

Kenvue Inc (KVUE) grafik logotipi

Kenvue Inc. (KVUE) o'zining yetakchi brendlari uchun xarajatlarni optimallashtirish va marja o'sishiga e'tibor qaratadi. Kompaniyaning qarzning kitob kapitalizatsiyasiga nisbati ushbu tendentsiyani vizuallashtiradi, 0.78 ko'rsatkichi esa moliyaviy barqarorlikning joriy darajasini tasdiqlaydi. J&J dan ajralishdan keyingi samarali boshqaruv dividendlarni kafolatlaydi, ammo chakana savdo do'konlarining shaxsiy brendlari tomonidan bosim va yuqori marketing xarajatlari sezilarli bozor risklarini yuzaga keltirmoqda.

KVUE (Kenvue Health) Qarzning balans qiymatiga nisbati tarixi 21.02.2024dan 27.10.2026gacha

Kenvue Inc (KVUE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Kenvue Inc.|KVUE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Kenvue Health|KVUE - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Kenvue|KVUE - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati kenvue.com|KVUE - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Kenvue Inc.|KVUE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Kenvue Corp|KVUE - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Kenvue Health
Kompaniyaning barcha koʻrsatkichlari tahlili:KVUE Kenvue Inc.
Kenvue Corp asosiy tovari

Ushbu koeffitsiyent umumiy kapital tuzilmasidagi qarz mablag'larining ulushini o'lchab, Kenvue Inc. (KVUE) ning kreditorlarga bo'lgan bog'liqligini va bozor zarbalariga nisbatan barqarorligini belgilaydi. Ish joyining barqarorligi va kuchli brend xavfsizlik zaxirasini tasdiqlaydi; shuning uchun, qarzning kapitalizatsiyani qoplash koeffitsiyentini tahlil qilish investorga moliyaviy leveraj va kompaniyaning resurslardan samarali foydalanishi o'rtasidagi muvozanatni baholash imkonini beradi.

Kenvue Inc. raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|veronapharma.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Jyong Biotech (MENS)|LGND: Qarzning sof aktivlarga nisbati|AMRX (Amneal Pharmaceuticals Inc) - Qarzning balans kapitallashuviga nisbati|Perrigo Corp (PRGO) - Qarzning balans qiymatiga nisbati|ALVO (Alvotech) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar liquidia.com (LQDA)|Galapagos (GLPG) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SXTC (sxtchina.com)|Qarzning balans kapitallashuviga nisbati EPRX (Eupraxia Pharmaceuticals Inc.)|Balans kapitallashuviga qarzlar BioHarvest Sciences, Inc. BHST|EXOZ (Invizyne Technologies, Inc.) - Balans kapitallashuviga qarzlar|ORMP: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati enterabio.com|Qarzning balans qiymatiga nisbati ipatherapeutics.com|Qarzning balans qiymatiga nisbati ABVC BioPharma, Inc.|Qarzning balans kapitallashuviga nisbati Cumberland Pharmaceuticals Inc (CPIX)|Qarzning balans qiymatiga nisbati QNTM|Balans kapitallashuviga qarzlar FibroGen Corporation (FGEN)|TELO: Balans kapitallashuviga qarzlar|RANI - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|RLYB - Qarzning sof aktivlarga nisbati|lexariabioscience.com - Balans kapitallashuviga qarzlar|PULM (Pulmatrix Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Pheton Holdings Limited (PTHL)|Qarzning balans qiymatiga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA (Lyra Therapeutics)|Qarzning balans qiymatiga nisbati Impact BioMedical, Inc. IBO|Qarzning balans qiymatiga nisbati TNFA|cbdMD Inc. - Sof aktivlarga qarzlar|PainReform Ltd. - Qarzning balans kapitallashuviga nisbati|Altamira Therapeutics (CYTO) - Balans kapitallashuviga qarzlar|Lipella Pharmaceuticals, Inc. (LIPO) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati OptiNose Inc|PIRS (Pieris) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Procaps Group Corp|Petros Pharmaceuticals - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar QLI (qlsyy.net)|ACELYRIN (SLRN) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati TFF Pharmaceuticals Inc. TFFP